Tuesday, July 31, 2018

Security Vulnerability Concerns Skyrocket as Neustar’s International Cyber Benchmark Index™ Hits Record High

Ninety percent of surveyed security professionals fear that

Meltdown-Spectre attacks are becoming the norm

STERLING, Va.-Friday 27 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Neustar®, Inc., a trusted, neutral provider of real-time information services, today released two new cybersecurity reports, reconfirming the need to take action in the face of increasing cyber threats. Both reports, The International Cyber Benchmarks Index and The Changing Face of Cyber Attacks, highlight that IT security professionals are more than twice as worried about data breaches and cyber-attacks today than they were this time last year.

The International Cyber Benchmarks Index is an initiative of the Neustar International Security Council (NISC), an elite group of select cyber security leaders across key industries, that assesses the international cybersecurity landscape from the vantage point of security professionals across the EMEA and U.S. regions. Other key findings from the most recent survey include:

-Greatest Threats: System compromises and ransomware are the greatest threats to organizations – with 20 percent listing both as their primary concern – closely followed by Distributed Denial of Service (DDoS) attacks (19 percent), financial theft (18 percent), and attacks on intellectual property (17 percent).
-Increasing Concern: 47 percent of security professionals see DDoS attacks as increasingly harmful to their organization this year, compared to 38 percent last year.
-No Sign of Slowing Down: 98 percent of companies surveyed have taken steps to minimize risks from the Meltdown-Spectre attack; nine out of ten respondents believe that these attacks will become the norm.
-Time to Mitigate: In 2017, half of the respondents claimed it would take them between 60 seconds and five minutes to act on an attack, with a quarter claiming it would only take 60 seconds, and the final 25 percent pushing the five-minute mark. Comparing this data to 2018, the clear majority (68 percent) still sit between 60 seconds and five minutes.

These numbers mirror data in Neustar's The Changing Face of Cyber Attacks report, which examined the effects of Memcached attacks and the largest DDoS attack ever recorded at 1.7Tbps. The study demonstrates how the different types of threats propagating today, combined with the sheer volume of attacks, can paint a discouraging picture. Even more alarming, however, is the fact that today’s threats seldom occur in isolation. For example, a DDoS threat in one segment can divert attention from malware in another, while ransomware can be used to hasten data exfiltration. Additional results show:

IPv6 attacks will rise as companies adopt the new standard. Neustar thwarted what is believed to be the first IPv6 attack –the attack presented a new direction that attackers are likely to pursue as more and more companies adopt IPv6 and run dual IPv4/IPv6 stacks.
IoT growth is paving the way for botnets, which are constantly evolving. Cyber criminals can rent or purchase these botnets with ease – making these threats one of the biggest issues for enterprises today.
Rodney Joffe, Head of NISC and Neustar Senior Vice President and Fellow, said, “While naturally distressing, these results should come as no surprise to anyone. Yes, security professionals are becoming more concerned about the level of threat to their organizations, because that same level of threat is continuing to rise at an extreme rate.”

“As we have seen over the past year, there are more threats to be aware of, whether in the form of DDoS, malware, application layer attacks or something else entirely, leaving professionals confused about where the next attack is coming from.”

“To successfully prepare for a cyber-attack in today’s landscape is to accept that your organization will be the next target. If you are online, you are susceptible to an attack. Whether you are most vulnerable or not is entirely up to you.”

About Neustar, Inc.

Neustar, Inc. is a leading global information services provider driving the connected world forward with responsible identity resolution. As a company built on a foundation of Privacy by Design, Neustar is depended upon by the world’s largest corporations to help grow, guard and guide their businesses with the most complete understanding of how to connect people, places and things. Neustar’s unique, accurate and real-time identity system, continuously corroborated through billions of transactions, empowers critical decisions across our clients’ enterprise needs. More information is available at https://www.home.neustar.

Contacts
Neustar Media Contact
Emma Yousif (Hotwire Global on behalf of Neustar)
neustar@Hotwireglobal.com
+44 (0) 207 608 4645

Permalink : http://aetoswire.com/news/security-vulnerability-concerns-skyrocket-as-neustarrsquos-international-cyber-benchmark-indextrade-hits-record-high/en

IDEMIA WISE Platform Delivers Contactless Payments as Confirmed by Proof of Concept

IDEMIA, the world leader in Augmented Identity, supported locally by ETC (Electronic Toll Collection system), has successfully completed a proof-of-concept to enable contactless/NFC payment in Vietnam.

COLOMBES, France-Tuesday 31 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Over the 3 month proof-of-concept with the National Payment Corporation of Vietnam (“NAPAS”), IDEMIA and NAPAS together found that under laboratory conditions, the WISE (White label Independent Secure EMV) kernel was proven to produce an open platform that was compatible with various form factors, applets and NAPAS chip card specifications. IDEMIA’s WISE HCE (Host Card Emulation) SDK Mobile Payment Engine designed to bring about HCE mobile payments was also covered by the proof of concept.

WISE is an EMV-compliant special feature that will pave the way for contactless payments. The feature is broadly supported, so it should be soon taken up by other parties involved in payment transaction security.

WISE is highly flexible and has been shown to support a large range of systems from domestic payment networks to ATM networks. Additional applications include “closed loop” public transit networks and non-cash transactions (such as passes and loyalty schemes). With 50 million-plus cards issued worldwide to date, WISE supports over 35 customers in several developed markets.

Minh Nguyen Quang, Napas Deputy CEO, said: “Backed by tremendous help from IDEMIA and ETC people, this successful proof of concept establishes beyond doubt that WISE is adaptable and can satisfy all payment needs. Buoyed by this initial success, we look forward immensely to teaming up with IDEMIA again to explore further how to bring about an open NFC payment ecosystem in Vietnam.”

Pierre Barrial, IDEMIA Executive VP, proudly exclaimed: “Our joint proof of concept with NAPAS is our first big step together and we will now ramp up joint projects with NAPAS looking to pave the way for a totally seamless payment experience in banking and other industries. IDEMIA has developed EMF-compliant WISE to support payment ecosystems when they switch over to chip and mobile payments. WISE features have been made flexible and scalable to satisfy local requirements and regulations.”

About IDEMIA

OT-Morpho is now IDEMIA, the global leader in trusted identities for an increasingly digital world, with the ambition to empower citizens and consumers alike to interact, pay, connect, travel and vote in ways that are now possible in a connected environment.

Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, we reinvent the way we think, produce, use and protect this asset, whether for individuals or for objects. We ensure privacy and trust as well as guarantee secure, authenticated and verifiable transactions for international clients from Financial, Telecom, Identity, Public Security and IoT sectors.

With close to €3bn in revenues, IDEMIA is the result of the coming together of OT (Oberthur Technologies) and Safran Identity & Security (Morpho). This new company counts 14,000 employees of more than 80 nationalities and serves clients in 180 countries.

For more information, visit www.idemia.com / Follow @IdemiaGroup on Twitter

Contacts
IDEMIA
Hanna Sebbah, +33 (0)6 63 73 30 30
Manon Gaudefroy, +33 (0)6 85 30 60 02
idemia@havas.com



Permalink : http://aetoswire.com/news/idemia-wise-platform-delivers-contactless-payments-as-confirmed-by-proof-of-concept/en

IDEMIA is the First Certified Card Manufacturer in India for Contactless RuPay Chip Cards, with the Facility to Load Multiple Payment Applications on a Single Card

COLOMBES, France-Tuesday 31 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- IDEMIA today announced that it is the first and, to date, only one to be certified to manufacture and personalise RuPay chip contact and contactless cards, on the qSPARC v2 platform.

qSPARC is a Dual Interface Open loop payment specification, with the option of loading multiple payment applications on a single card. This certification is issued by NPCI, after testing all payment scenarios and thus ensuring that, the cards manufactured by IDEMIA will work seamlessly at all payment acceptance devices.

The cardholders get the convenience of using a single card for multiple payment use cases such as; Metro, Bus, toll, loyalty, Parking and payments at retail. There is an option of loading up to 20 such payment applications on a single card.

The qSPARC is likely to steer the National Common Mobility Card (NCMC) and will be widely used in the Smart Cities. The first version of this card is deployed in Kochi Metro, Bangalore Bus Transport, Ahmedabad Smart City and will soon be delivered to prospective customers in Nagpur, Noida Metro and Navi Mumbai bus transport ticketing.

As of now, more than 1.5 million cards have been issued.

"This certification recognizes IDEMIA’s commitment to continually invest in the development of technologies for enhancing and securing the payment experience for Indians and establishes once again our leadership in this space”, said Sanjeev Shriya, Regional President for IDEMIA’s activities in India. "This qSPARC certification will increase the usability of bank issued cards with an enhanced value proposition for all stakeholders”.

About IDEMIA
OT-Morpho is now IDEMIA, the global leader in Augmented Identity for an increasingly digital world, with the ambition to empower citizens and consumers alike to interact, pay, connect, travel and vote in ways that are now possible in a connected environment.

Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, we reinvent the way we think, produce, use and protect this asset, whether for individuals or for objects. We ensure privacy and trust as well as guarantee secure, authenticated and verifiable transactions for international clients from Financial, Telecom, Identity, Public Security and IoT sectors.

OT (Oberthur Technologies) and Safran Identity & Security (Morpho) have joined forces to form IDEMIA. With close to $3 billion in revenues and 14,000 employees around the world, IDEMIA serves clients in 180 countries.

For more information, visit www.idemia.com / Follow @IdemiaGroup on Twitter

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180730005268/en/

Contacts

Press:
Havas Paris PR Agency
Hanna Sebbah, T +33 (0)6 63 73 30 30
idemia@havas.com

Permalink : http://aetoswire.com/news/idemia-is-the-first-certified-card-manufacturer-in-india-for-contactless-rupay-chip-cards-with-the-facility-to-load-multiple-payment-applications-on-a-single-card/en

Quanergy Achieves IATF 16949 Automotive Production Certification

 LiDAR manufacturer reaches significant milestone for automotive solid state sensor production

SUNNYVALE, Calif.-Tuesday 31 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Quanergy Systems, Inc., a global leader in the design and development of solid state LiDAR sensors and smart sensing solutions, today announced that the production line for its solid state LiDAR sensors has achieved IATF 16949 certification.

The International Automotive Task Force (IATF) 16949 is a certification that denotes requirements for a quality management system for organizations within the automotive industry. To qualify and meet certification requirements, Quanergy’s solid state LiDAR production line underwent a thorough quantitative assessment, which consists of 113 tasks within 5 stages that are based on stringent automotive requirements and data obtained through Statistical Process Control (SPC) and Measurement System Analysis (MSA).

The qualification criteria to meet this certification requirement are critical steps towards Quanergy’s goal to bring automotive-grade solid state LiDAR sensors to market. Automotive-grade LiDAR sensors are built using rigorous production processes, which must pass tests that significantly reduce the failure rate of the sensors. While the certification process takes 24 months on average, as a result of Quanergy’s automated facilities, the company was able to gain qualification of this certification in 18 months.

“This latest certification of our production line is a monumental milestone for Quanergy and for the entire LiDAR community,” said Dr. Louay Eldada, CEO of Quanergy. “As automotive and technology companies converge towards a driverless future, the ability to produce automotive-grade solid state LiDAR sensors will be vital. As a result of our team’s hard work and commitment to achieving this certification, Quanergy is leading the way towards this reality.”

Quanergy’s vice president of quality and reliability, Bruce Shibuya, led Quanergy’s various departments and teams to meet this quality standard and achieve qualification of the IATF 16949 certification. Using advanced product quality planning (APQP), Shibuya coordinated internal teams across engineering, production, manufacturing and quality to run reliability tests on all components and completed assemblies as well as qualify the products to meet a strict set of requirements (e.g., thermal cycling, mechanical shock, electrical stress). An industry veteran, Shibuya has established high standards for product quality and reliability as the head of quality departments at companies including Toyota/Lexus, Hyundai/Kia, Nvidia and Jabil.

“IATF 16949 certification opens many doors for Quanergy, which is why our team poured so much effort into earning this distinction,” said Bruce Shibuya, Vice President of Quality and Reliability at Quanergy. “Going through this extremely rigorous process validated our understanding that Quanergy’s products are superior in terms of quality and reliability in all business segments that we are engaged in.”

This qualification of the certification follows the announcement earlier this month that Quanergy obtained another critical quality certification, ISO 9001:2015. As a result of these certifications, Quanergy will now begin mass production of its S3 solid state sensor on its newly certified line.

About Quanergy Systems, Inc.

Quanergy Systems was founded in 2012 and builds on decades of experience of its team in the areas of optics, photonics, optoelectronics, robotics, artificial intelligence, machine learning and controls. Headquartered in Sunnyvale, California, in the heart of Silicon Valley, Quanergy offers the world’s leading LiDAR sensors and software for the capture and processing of 3D spatial data, and object detection, tracking and classification. Its sensing systems improve safety, efficiency and costs in sectors ranging from transportation and security to industrial automation and 3D terrestrial and aerial mapping. In transportation, the data is utilized in real time to greatly improve the accuracy and reliability of on-board driver safety systems and enhance them with perception, scenario analysis, and decision making capability for cost-effective and robust advanced driver assistance systems (ADAS) and autonomous vehicle (AV) solutions. Quanergy’s LiDAR leads in all key commercialization areas – price, performance, reliability, size, weight, power efficiency. For more information, visit www.quanergy.com.

Contacts

Quanergy Systems, Inc.
Ann Gargiulo, +1-408-245-9500
Sr. Director, Marketing Communications
media@quanergy.com


Permalink : http://aetoswire.com/news/quanergy-achieves-iatf-16949-automotive-production-certification/en

Fakih IVF Fertility Center Launches CSR Initiative to Commemorate the Year of Zayed

 • CSR Initiative pays tribute to the late Sheikh Zayed bin Sultan Al Nahyan’s Vision by further strengthening the transformation of the region’s healthcare sector

• CSR Initiative aims to help patients achieve their dreams through intelligent and affordable fertility solutions.


Dubai, United Arab Emirates-Monday 30 July 2018 [ AETOS Wire ]

Fakih IVF Fertility Center, one of the leading Infertility, Gynecology, Obstetrics, Genetics and IVF centers in the GCC region, has announced the launch of its CSR Initiative to commemorate the Year of Zayed, which marks 100 years since the birth of the late Sheikh Zayed bin Sultan Al Nahyan, the Founding Father of the UAE.

Fakih IVF Fertility Center’s mission is to continually strive to improve medical protocols and invest in the newest technologies in order to excel in their commitment to help families grow and ultimately achieve the highest success rates. As part of its mission, the newly-launched CSR Initiative aims to promote the delivery of quality and affordable healthcare options to all segments of society, an area which the late Sheikh Zayed was passionate about.

The CSR Initiative helps patients achieve their dreams through intelligent and affordable fertility solutions. As part of the initiative, Fakih IVF is offering adult females and couples, of all age groups, an AED 8,000 discount on all IVF-ICSI (intracytoplasmic sperm injection treatment), as well as a 10 per cent discount on all other IVF treatments. This contribution is valid to all patients at Fakih IVF Clinic in Dubai until 31 August 2018.

Dr. Michael Fakih, Founder and Consultant in Reproductive Endocrinology and IVF at Fakih IVF Fertility Center lauded the foresight and generosity of the late Sheikh Zayed, whose vision and legacy have directly impacted the lives of millions of people in the UAE and around the world, many of whom have been beneficiaries of his philanthropic activities.  Dr. Fakih said: “The UAE is leading the region in providing charitable initiatives that support the physical and emotional well-being of deserving people across the globe. Fakih IVF is especially honoured, on the occasion of the one hundred years since the birth of Sheikh Zayed, to pay tribute to his vision by further strengthening the transformation the region’s healthcare sector. We are stepping up to provide affordable fertility care to our patients, as we believe that all couples deserve the kind of treatment that makes the most of their chances for having a baby — at a fair price. With our CSR initiative, the emphasis shifts from the cost of treatment to the cost of having a baby.”

Mrs. Wafaa El Ali, Deputy CEO at Fakih IVF Fertility Center, said: “Our ongoing initiative benefits both our new and existing patients to a great extent, as most patients who undergo IVF treatment most often chose IVF-ICSI, an expensive option, so this offer represents a considerable monetary value to those who are financially challenged.”


About Fakih IVF Fertility Center

Fakih IVF is the only fertility center in the Middle East that is equipped with a state-of-the-art Genetics Laboratory, offering a screening of hereditary diseases, chromosomal abnormalities, and gender selection.

With centers in Abu Dhabi and Dubai and medical partners in Al Ain, Fakih IVF Fertility Center is available to help couples throughout the UAE and abroad. Fakih IVF Fertility Center has a high rate of success in its wide variety of assisted reproduction treatments. Treatment options include IVF-ICSI, Natural Cycle IVF, Mini IVF, IUI, Gender Selection, Comprehensive Chromosomal Screening (CCS), Screening for hereditary diseases through PGD, Male Infertility and much more.

Contacts

SAHARA Communications

Dr. Marwan Al-Najjar, Senior Projects Manager, +971562634886, +97143298996
m.alnajjar@saharapr.com / www.saharagcc.com

Permalink : http://aetoswire.com/news/fakih-ivf-fertility-center-launches-csr-initiative-to-commemorate-the-year-of-zayed/en

58-year-old American Undergoes Fat Reduction Procedure Post-Cancer Battle

The patient undergoes Cool Sculpting to achieve dramatic body transformation


Dubai, United Arab Emirates-Monday 30 July 2018 [ AETOS Wire ]

A 58-year-old American woman may have survived two different forms of cancer, but the stubborn fat on her body just wouldn’t wade off. However, determined to get rid of troubled areas on her body, she opted for CosmeSurge’s Cool Sculpting – a fat freezing process to stride off the unwanted fat.

There’s an emotional toll that a cancer patient faces when fighting for her life, but that’s just one part of the whole journey. Cancer, and it’s various forms of treatment, may have a strong impact on a person’s physical stature as well. Chemotherapy and steroids are two of the more well-known treatments of cancer, however, they also have appearance-altering side effects, and to be able to feel good about herself after her intense treatment, the patient choose Cool Sculpting to regain her confidence back.  According to cancer.net, some of the side effects include:

Intense food cravings
Increase in appetite
An increase in fatty tissue
A noticeable increase in weight
Imagine enduring the fight of a lifetime and, at the end of it, you’re physically unrecognizeable. It shouldn’t be that way, and it doesn’t have to be. Cool Sculpting is a safe non-invasive body contouring fat reduction procedure, which freezes the fat in the area to be treated. When the fat cells are frozen it causes them to die and be removed from the body as waste. This procedure is seen as more effective than other non-invasive fat reduction treatments and has fewer risks and complication than surgical treatments like liposuction. The entire procedure is about 35 minutes to an hour, and generally takes 8-10 weeks for the results to show.

“We all have certain areas on our body that we wish we could tone up. When the cancer patient visited us for the first time, she was determined to feel good about herself, in spite of going through vigorous chemotherapy to treat her cancer. As such, we decided to perform Cool Sculpting. It was a total body transformation process for her, which involved treating her abdomen, back, arms, and legs. The results were dramatically positive, leaving her thrilled,” said, Dr Lana Kashlan, Consultant Dermatologist at CosmeSurge.

Dr Kashlan explains that Cool Sculpting is not a weight loss treatment. It is a fat reduction process, and is designed for people who live active lifestyles, experience minimal weight fluctuations and are looking to target certain areas of the body that are resistant to exercise and healthy eating habits.

“One important reason that most people in the UAE opt for Cool Sculpting is that it is a significantly safer procedure as compared to other fat reduction treatments. It is non-invasive as it doesn’t make use of needles, cuts or anaesthesia. In addition, there is no downtime or discomfort that patients have to experience with this procedure,” concluded Dr Kashlan.

Contacts
SAHARA Communications

Maria F. Tayem, Senior Account Manager, +971501714347, +97143298996
m.tayem@saharapr.com / www.saharagcc.com




Permalink : http://aetoswire.com/news/58-year-old-american-undergoes-fat-reduction-procedure-post-cancer-battle/en

TRIGO Widens its Service Portfolio and Sector Exposure by Acquiring SCSI

PARIS-Monday 30 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- TRIGO has acquired 100% of the capital of Supply Chain Services International, otherwise known as SCSI. SCSI is headquartered in Peoria, Illinois, USA, with operations in the United States, Europe and Asia. This acquisition supports TRIGO’s strategy to expand its service portfolio towards advanced supply chain services and to penetrate new market segments within the transportation industry.

Co-founded in 2001 by Pierre Lewin and Patrick Peronnet to strengthen relationships between suppliers and OEMs by helping them meet demand, in spec and on time, avoiding line down situations, SCSI has developed a unique expertise in designing and delivering sophisticated supply chain and quality management solutions to the off-highway vehicles market.

“The acquisition of SCSI strengthens our global market leadership by providing a unique portfolio of high performance quality management solutions to international manufacturing supply chains. Furthermore, I am very happy to welcome SCSI’s talented professionals to TRIGO with their proven expertise and customer focus” said Matthieu Rambaud, CEO of TRIGO.

“I am super excited about the perspective of providing our customers an exponential increase of capabilities around the world with a team that shares the same commitment and customer-oriented approach” said Pierre Lewin. “SCSI is our baby and it has been an amazing journey. I am thrilled to be part of its next chapter and continued growth within a mature and successful group that is TRIGO”, Patrick Peronnet added.

This is the second acquisition for TRIGO in 2018 and the sixth one since private equity firm ARDIAN began backing TRIGO in 2016.

About SCSI

For nearly 20 years, SCSI has provided quality inspection, reactive containment, and logistics throughout the supply chain for some of the most successful OEMs and suppliers in the world. We’re there where you need us, in our facility, at the OEM, or at the supplier. No matter where you are in the world, SCSI can handle it for you.

http://www.scsinternational.com

About TRIGO Group

Founded in 1997, TRIGO is a multinational company providing operational Quality Management solutions for the manufacturing sector, especially within the automotive and aerospace industries. With a team of several thousand professionals present in 20+ countries across 4 continents, TRIGO offers a comprehensive portfolio of quality assurance services ranging from inspection to expert auditing, consulting and training.

https://www.trigo-group.com



Contacts
TRIGO
Mercédesz TRUM, +36304858353
Group Marketing Director
mercedesz.trum@trigo-group.com




Permalink : http://aetoswire.com/news/trigo-widens-its-service-portfolio-and-sector-exposure-by-acquiring-scsi/en

Monday, July 30, 2018

Increase in GCC Tourists Expected in Antigua and Barbuda with the Opening of New 5-Star Hotels


Antigua and Barbuda-Monday 30 July 2018 [ AETOS Wire ]

With many countries looking to attract GCC tourists due to factors such as their large groups, longer stays and high levels of spending, Antigua and Barbuda is a country that is setting the right platform.

GCC tourist numbers are set to climb next year with new five-star hotels opening. The islands are undergoing rapid development and tourists from the GCC region are expected to consider Antigua and Barbuda as an attractive destination.

The twin islands, with 365 sandy beaches to choose from and sparkling clear warm water, is reporting significant growth in tourists so far in 2018, with a more than seven per cent increase compared to the first half of 2017.

Antigua and Barbuda Minister of Tourism and Investment, Charles ‘Max’ Fernandez, said: “We are looking forward to more tourists from the GCC region visiting the islands. Brands such as Rosewood, Waldorf Astoria, Best Western Premier and Marriott, have recently invested in high-end luxury accommodation on the islands.”

Mr. Fernandez added: “We are excited by this positive momentum in growth of arrivals, both by cruise and air. It is incredibly encouraging for the tourism industry, and I would like to congratulate the Antigua and Barbuda Tourism Authority, the private sector, stakeholders and all our tourism partners on helping us reach these positive results for the first six months of the year.

“We will not rest on our laurels and are striving for better. We will continue to invest in infrastructure and service and raise awareness of Antigua and Barbuda, to ensure we see consistent growth in tourist flow.”

Also, Barbados-based company, Elegant Hotels, is spearheading a new Hodges Bay project. The five-star Hodges Bay is set to open in the autumn.

Contacts

SAHARA Communications                                                                      

Farah Al Obaidi, Head of Media Relations, +97143298996, +971503323158
farah@saharagcc.com, www.saharagcc.com



Permalink : http://aetoswire.com/news/increase-in-gcc-tourists-expected-in-antigua-and-barbudanbspwith-the-opening-of-new-5-star-hotels/en

Chartbeat Announces New Funding to Fuel Growth

NEW YORK-Thursday 26 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Chartbeat, the content intelligence platform for the world’s leading publishers, today announced that the company has closed a $7 million funding round, led by North Atlantic Capital. The capital will enable Chartbeat to accelerate its leadership position in real-time analytics across desktop, social, and mobile platforms.

2018 has seen unprecedented traffic shifts, and Chartbeat provides media organizations with instant insights about content engagement and reader traffic — whether directly on publisher websites or from platforms such as Facebook and Google. Empowered with data, media organizations can better understand, measure, and build business value from the attention earned by their content.

“Our solid revenue growth and product expansion efforts have put us on a bright path forward,” said John Saroff, Chartbeat’s CEO. “We’re thrilled to have North Atlantic Capital behind us as we continue to scale.” Saroff added, “Chartbeat’s analytics enable publishers to connect with valuable readers and grow a sustainable business. We’ll continue to build out our core business while expanding into new areas within mobile and multivariate testing.”

Today's investment follows a period of rapid growth for Chartbeat, whose customer base now includes the top global media, sports and entertainment brands in over 65 countries. Clients include The New York Times, The Washington Post, The Atlantic and ESPN in the US; the Economist, The Telegraph and The Mirror in the UK; Le Figaro and Le Monde in France, Unidad in Spain; Clarin in Argentina; and The South China Morning Post in Hong Kong, to name a few.

"This is a very strong team – impressively talented and dedicated to solving a real need for publishers," said Mark Morrissette, Managing Director at North Atlantic Capital. “With such passionate customers, we see a lot of opportunity for Chartbeat to expand both within its base and into adjacent markets. This is a great fit for us.”

This late stage funding brings the total amount of money Chartbeat has raised since 2009 to $38 million. North Atlantic will immediately join Chartbeat’s Board of Directors as a board observer, along with investors and board members DFJ, Index Ventures and Betaworks, and board observer Harmony Partners.

About Chartbeat

Chartbeat, the content intelligence platform for publishers, empowers media companies to build loyal audiences with real-time and historical editorial analytics across desktop, social, and mobile platforms. Chartbeat helps digital publishing organizations understand what, within their content, is keeping people engaged. Partnering with thousands of customers across 65 countries, Chartbeat’s real-time and historical dashboards, in-depth headline testing and in-page optimization tools, robust reporting, and APIs help the world’s leading media organizations understand, measure, and build business value from the attention earned by their content.

About North Atlantic Capital

North Atlantic Capital provides growth capital to innovative technology companies across the United States. Founded in 1986 and based in Portland, Maine, the firm is currently investing its fifth fund, which is capitalized at more than $120 million. North Atlantic targets high-growth, later-stage technology businesses with annual revenues of more than $10 million. North Atlantic has a 30-year history of supporting rapidly growing technology companies with both equity and long-term subordinated investments. https://www.northatlanticcapital.com/



Contacts

Media
Chartbeat
Terri Walter, 646-932-7654
or
Lauryn Bennett, 781-635-6141
press@chartbeat.com



Permalink : http://aetoswire.com/news/chartbeat-announces-new-funding-to-fuel-growth/en

The Earth Trembles in Abu Dhabi As UNITE With Tomorrowland Unveils a Spectacular 2nd Edition

 ~ Du Forum, Yas Island transformed into an anchorage of dance and music with a live satellite connecting more than 400,000 fellow people of Tomorrowland across the globe ~



Abu Dhabi, United Arab Emirates-Monday 30 July 2018 [ AETOS Wire ]

Du Forum, Yas Island was packed with a celebrated crowd full of energy who couldn’t stop dancing all night and thumping their feet to the mind-blowing beats. UNITE with Tomorrowland Abu Dhabi at Du Forum on 28th July 2018 outshined impressively while spreading the magic in the air. The party kicked off with SMOKINGROOVE and MARCUS SANTORO creating the perfect celebratory atmosphere. Following suit, massive weight was added to the performance line-up by artists like the scintillating duo LUCAS & STEVE, REGI, BARRY FORE, OMAR BASAAD, D.O.D & UMMET OZCAN who flew from the Holy Grounds of Belgium’s Tomorrowland to Abu Dhabi to get the crowd moving to their beats!

Festival-goers set out on this unforgettable journey with show-stopping performances via a live satellite connection from Afrojack, Armin van Buuren, Dimitri Vegas & Like Mike from the Mainstage in Boom, Belgium. This playground of magic ensured the crowd in Abu Dhabi had the global magical experience of Tomorrowland right on the dance floor at Du Forum. The event showcased live footage from Tomorrowland in Belgium, as well as UNITE With Tomorrowland taking place in seven different locations around the world. Audiences were able to experience the charm of Tomorrowland and share the love of this beautiful festival, which united EDM lovers across the globe. UNITE with Tomorrowland Abu Dhabi was surrounded by the indescribable and surreal Tomorrowland vibe. With one of the biggest and most unforgettable parties ever, Tomorrowland teased fans with its ‘The Story of Planaxis’ theme which brought alive all manner of magical oddities from around the world.

UNITE with Tomorrowland Abu Dhabi presented a custom built stage which showcased synchronised lighting and effects across all eight locations around the world. The one-of-a-kind stage kept audiences enthralled throughout the event and it was a show that will be remembered in years to come.

Nicolas Van denAbeele, Director, Envie Events said, “It’s been an absolute pleasure opening the doors once again to UNITE with Tomorrowland, this time in Abu Dhabi as part of the Abu Dhabi Summer Season. Du Forum and Yas island were the perfect partners and hosts to welcome the international crowd of UNITE With Tomorrowland. I was overwhelmed with the sky-rocketing energy and the magical celebration on the dance floor, can’t wait to be back!”

Link to download high resolution images of the event in Abu Dhabi: https://www.dropbox.com/sh/l5ckuhop64dgps4/AAA6SsnL78YUzkkX-muQRATFa?dl=0

About Envie Events

Envie Events is proud producer, organizer and promoter of some of the most spectacular, immersive and innovative Dance Music Events in the Middle East including Sensation Dubai, Martin Garrix on NYE 2015, I am Hardwell 2016, Armin Only Embrace 2016.

With over 25 years of combined experience in the entertainment, hospitality, and nightlife industry, the company’s events captivate tour senses and inspire a unique level of fan interaction enhanced by state-of-the-art lighting, pyrotechnics and sound design, large-scale art installations and theatrical performers. Having hosted the first world exclusive open-air edition of Sensation in Dubai, two Mega Night Club operations in Europe and various annual partnerships with globally-renowned concepts such as Sensation, Tomorrowland, WMC Miami, and Summer Clubbing Ibiza, Envie Events aspires to become the ultimate destination of choice for events and concerts in Dubai – attracting the entire MENA Region and beyond.



Contacts

Henna Peswani, +971529549333

henna.peswani@mediaagency-me.com

Permalink : http://aetoswire.com/news/the-earth-trembles-in-abu-dhabi-as-unite-with-tomorrowland-unveils-a-spectacular-2nd-edition/en

Toshiba Experiences Nearly 50 Percent Growth in Self-Checkout Market Share

RBR Report Establishes Toshiba as World’s Fastest-Growing Major Self-Checkout Manufacturer


RESEARCH TRIANGLE PARK, N.C.-Monday 30 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Toshiba Global Commerce Solutions (TGCS), the global market share leader in installed retail point of sale (EPOS) technology, has rapidly grown its worldwide self-checkout (SCO) market share by 46 percent, according to research and consulting company RBR.

Toshiba’s overall share of the self-checkout market now stands at 21 percent affirms RBR’s Global EPOS (electronic point of sale) and Self-Checkout 2018 report. RBR’s data also establishes Toshiba’s position as the world’s fastest-growing major manufacturer of self-checkout solutions. The study further validates Toshiba as the global leader in EPOS with a 25 percent install share – more than the combined installed base share of its closest two competitors.

RBR reports SCO shipments reached a new record level in 2017 with 63,000 systems delivered, while forecasting 445,000 such products will be installed by 2023. RBR’s Global EPOS and Self-Checkout 2018 study is based on in-depth primary research, and provides detailed, country-by-country data and commentary for programmable EPOS and self-checkout hardware in 53 markets.

Toshiba recently introduced its next-generation Self Checkout System 7 platform, enabling retailers to customize in-store environments while providing shoppers a fast, personalized checkout experience. Toshiba’s latest solution is currently drawing significant interest from prominent retail and grocery stores throughout the world.

“Toshiba's innovation in self-service continues with integrated solutions designed to deliver enriched shopping experiences while removing friction from retail operations,” said Bill Melo, Toshiba Global Commerce Solutions chief marketing executive.

“With our unique next-generation platform and proven engagement methodology, we remain committed to helping our clients drive significant ROI and greater customer satisfaction."

About Toshiba Global Commerce Solutions

As the market share leader in retail store technology, Toshiba’s Brilliant Commerce™ enables retailers to deliver engaged shopping experiences, gain actionable insights and provide frictionless checkout.

With a global team of dedicated business partners, we deliver innovative commerce solutions that transform checkout, provide seamless consumer interactions and optimize retail operations that are changing the retail landscape. To learn more, visit toshibacommerce.com or engage on Twitter @toshibagcs.

Contacts

Media Contact:
Toshiba Global Commerce Solutions, Inc.
Fredrik Carlegren, 1.984.444.2769
Toshiba_Comms@toshibagcs.com

Permalink : http://aetoswire.com/news/toshiba-experiences-nearly-50-percent-growth-in-self-checkout-market-share/en

Takeda Announces Phase 3 Trial of ALUNBRIG® (brigatinib) Met Primary Endpoint Demonstrating Superiority in Progression-Free Survival Versus Crizotinib in Patients with ALK+ Advanced NSCLC Who are ALK Inhibitor Naïve

CAMBRIDGE, Mass. & OSAKA, Japan-Friday 27 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the global, randomized, Phase 3 ALTA-1L (ALK in Lung Cancer Trial of AP26113 in 1st Line) trial met its primary endpoint at the first pre-specified interim analysis, with ALUNBRIG® (brigatinib) demonstrating a statistically significant improvement in progression-free survival (PFS) compared to crizotinib in adults with anaplastic lymphoma kinase-positive (ALK+) locally advanced or metastatic non-small cell lung cancer (NSCLC) who had not received a prior ALK inhibitor. The trial was designed to assess the efficacy and safety of ALUNBRIG in comparison to crizotinib based on evaluation of the primary endpoint of PFS, or length of time from the start of treatment that a patient lives without the disease getting worse. ALUNBRIG is currently not approved as frontline therapy.

“This represents a major milestone for the ALUNBRIG program. Our goal with ALUNBRIG is to improve the lives of patients with ALK+ NSCLC by furthering the available therapeutic options,” said Jesús Gomez-Navarro, M.D., Vice President, Head of Oncology Clinical Research and Development, Takeda. “We are encouraged by the data, which demonstrated a statistically significant improvement in progression-free survival versus crizotinib in patients with ALK+ advanced NSCLC, and look forward to beginning discussions with regulatory authorities as we seek to expand ALUNBRIG’s indication into the frontline setting.”

The safety profile associated with ALUNBRIG from the ALTA-1L trial was generally consistent with the existing prescribing information, with no new safety concerns.

The results from this interim analysis will be submitted for presentation at an upcoming medical meeting.

About the ALTA-1L Trial

The Phase 3 ALTA-1L (ALK in Lung Cancer Trial of AP26113 in 1st Line) trial of ALUNBRIG in adults is a global, ongoing, randomized, open-label, comparative, multicenter trial, which enrolled 275 patients with ALK+ locally advanced or metastatic NSCLC who have not received prior treatment with an ALK inhibitor. Patients received either ALUNBRIG, 180 mg once daily with seven-day lead-in at 90 mg once daily, or crizotinib, 250 mg twice daily. Independent Review Committee (IRC)-assessed progression-free survival (PFS) was the primary endpoint. Secondary endpoints included objective response rate (ORR) per RECIST v1.1, intracranial ORR, intracranial PFS, overall survival (OS), safety and tolerability. A total of approximately 198 PFS events are planned at the final analysis of the primary endpoint in order to demonstrate a minimum of six months PFS improvement over crizotinib. The trial is designed with two pre-specified interim analyses for the primary endpoint – one at 50 percent of planned PFS events and one at 75 percent of planned PFS events.

About ALK+ NSCLC

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for approximately 85 percent of the estimated 1.8 million new cases of lung cancer diagnosed each year worldwide, according to the World Health Organization. Genetic studies indicate that chromosomal rearrangements in anaplastic lymphoma kinase (ALK) are key drivers in a subset of NSCLC patients. Approximately three to five percent of patients with metastatic NSCLC have a rearrangement in the ALK gene.

Takeda is committed to continuing research and development in NSCLC to improve the lives of the approximately 40,000 patients diagnosed with this serious and rare form of lung cancer worldwide each year.

About ALUNBRIG® (brigatinib)

ALUNBRIG is a targeted cancer medicine discovered by ARIAD Pharmaceuticals, Inc., which was acquired by Takeda in February 2017. In April 2017, ALUNBRIG received Accelerated Approval from the U.S. Food and Drug Administration (FDA) for ALK+ metastatic NSCLC patients who have progressed on or are intolerant to crizotinib. This indication is approved under Accelerated Approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

ALUNBRIG received Breakthrough Therapy Designation from the FDA for the treatment of patients with ALK+ NSCLC whose tumors are resistant to crizotinib and was granted Orphan Drug Designation by the FDA for the treatment of ALK+ NSCLC, ROS1+ and EGFR+ NSCLC. A Marketing Authorization Application (MAA) for ALUNBRIG was submitted to the European Medicines Agency (EMA) in February 2017.

The brigatinib clinical development program further reinforces Takeda’s ongoing commitment to developing innovative therapies for people living with ALK+ NSCLC worldwide and the healthcare professionals who treat them. The comprehensive program includes the following clinical trials:

    Phase 1/2 trial, which was designed to evaluate the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of ALUNBRIG
    Pivotal Phase 2 ALTA trial investigating the efficacy and safety of ALUNBRIG at two dosing regimens in patients with ALK+ locally advanced or metastatic NSCLC who had progressed on crizotinib
    Phase 3 ALTA-1L trial assessing the efficacy and safety of ALUNBRIG in comparison to crizotinib in patients with ALK+ locally advanced or metastatic NSCLC who have not received prior treatment with an ALK inhibitor
    Phase 2 single-arm, multicenter study in Japanese patients with ALK+ NSCLC, focusing on patients who have progressed on alectinib
    Phase 2 global study evaluating ALUNBRIG in patients with advanced ALK+ NSCLC who have progressed on alectinib or ceritinib

For additional information on the brigatinib clinical trials, please visit www.clinicaltrials.gov.

IMPORTANT SAFETY INFORMATION (U.S.)

WARNINGS AND PRECAUTIONS

Interstitial Lung Disease (ILD)/Pneumonitis: Severe, life-threatening, and fatal pulmonary adverse reactions consistent with interstitial lung disease (ILD)/pneumonitis have occurred with ALUNBRIG. In Trial ALTA (ALTA), ILD/pneumonitis occurred in 3.7% of patients in the 90 mg group (90 mg once daily) and 9.1% of patients in the 90→180 mg group (180 mg once daily with 7-day lead-in at 90 mg once daily). Adverse reactions consistent with possible ILD/pneumonitis occurred early (within 9 days of initiation of ALUNBRIG; median onset was 2 days) in 6.4% of patients, with Grade 3 to 4 reactions occurring in 2.7%. Monitor for new or worsening respiratory symptoms (e.g., dyspnea, cough, etc.), particularly during the first week of initiating ALUNBRIG. Withhold ALUNBRIG in any patient with new or worsening respiratory symptoms, and promptly evaluate for ILD/pneumonitis or other causes of respiratory symptoms (e.g., pulmonary embolism, tumor progression, and infectious pneumonia). For Grade 1 or 2 ILD/pneumonitis, either resume ALUNBRIG with dose reduction after recovery to baseline or permanently discontinue ALUNBRIG. Permanently discontinue ALUNBRIG for Grade 3 or 4 ILD/pneumonitis or recurrence of Grade 1 or 2 ILD/pneumonitis.

Hypertension: In ALTA, hypertension was reported in 11% of patients in the 90 mg group who received ALUNBRIG and 21% of patients in the 90→180 mg group. Grade 3 hypertension occurred in 5.9% of patients overall. Control blood pressure prior to treatment with ALUNBRIG. Monitor blood pressure after 2 weeks and at least monthly thereafter during treatment with ALUNBRIG. Withhold ALUNBRIG for Grade 3 hypertension despite optimal antihypertensive therapy. Upon resolution or improvement to Grade 1 severity, resume ALUNBRIG at a reduced dose. Consider permanent discontinuation of treatment with ALUNBRIG for Grade 4 hypertension or recurrence of Grade 3 hypertension. Use caution when administering ALUNBRIG in combination with antihypertensive agents that cause bradycardia.

Bradycardia: Bradycardia can occur with ALUNBRIG. In ALTA, heart rates less than 50 beats per minute (bpm) occurred in 5.7% of patients in the 90 mg group and 7.6% of patients in the 90→180 mg group. Grade 2 bradycardia occurred in 1 (0.9%) patient in the 90 mg group. Monitor heart rate and blood pressure during treatment with ALUNBRIG. Monitor patients more frequently if concomitant use of drug known to cause bradycardia cannot be avoided. For symptomatic bradycardia, withhold ALUNBRIG and review concomitant medications for those known to cause bradycardia. If a concomitant medication known to cause bradycardia is identified and discontinued or dose adjusted, resume ALUNBRIG at the same dose following resolution of symptomatic bradycardia; otherwise, reduce the dose of ALUNBRIG following resolution of symptomatic bradycardia. Discontinue ALUNBRIG for life-threatening bradycardia if no contributing concomitant medication is identified.

Visual Disturbance: In ALTA, adverse reactions leading to visual disturbance including blurred vision, diplopia, and reduced visual acuity, were reported in 7.3% of patients treated with ALUNBRIG in the 90 mg group and 10% of patients in the 90→180 mg group. Grade 3 macular edema and cataract occurred in one patient each in the 90→180 mg group. Advise patients to report any visual symptoms. Withhold ALUNBRIG and obtain an ophthalmologic evaluation in patients with new or worsening visual symptoms of Grade 2 or greater severity. Upon recovery of Grade 2 or Grade 3 visual disturbances to Grade 1 severity or baseline, resume ALUNBRIG at a reduced dose. Permanently discontinue treatment with ALUNBRIG for Grade 4 visual disturbances.

Creatine Phosphokinase (CPK) Elevation: In ALTA, creatine phosphokinase (CPK) elevation occurred in 27% of patients receiving ALUNBRIG in the 90 mg group and 48% of patients in the 90 mg→180 mg group. The incidence of Grade 3-4 CPK elevation was 2.8% in the 90 mg group and 12% in the 90→180 mg group. Dose reduction for CPK elevation occurred in 1.8% of patients in the 90 mg group and 4.5% in the 90→180 mg group. Advise patients to report any unexplained muscle pain, tenderness, or weakness. Monitor CPK levels during ALUNBRIG treatment. Withhold ALUNBRIG for Grade 3 or 4 CPK elevation. Upon resolution or recovery to Grade 1 or baseline, resume ALUNBRIG at the same dose or at a reduced dose.

Pancreatic Enzyme Elevation: In ALTA, amylase elevation occurred in 27% of patients in the 90 mg group and 39% of patients in the 90→180 mg group. Lipase elevations occurred in 21% of patients in the 90 mg group and 45% of patients in the 90→180 mg group. Grade 3 or 4 amylase elevation occurred in 3.7% of patients in the 90 mg group and 2.7% of patients in the 90→180 mg group. Grade 3 or 4 lipase elevation occurred in 4.6% of patients in the 90 mg group and 5.5% of patients in the 90→180 mg group. Monitor lipase and amylase during treatment with ALUNBRIG. Withhold ALUNBRIG for Grade 3 or 4 pancreatic enzyme elevation. Upon resolution or recovery to Grade 1 or baseline, resume ALUNBRIG at the same dose or at a reduced dose.

Hyperglycemia: In ALTA, 43% of patients who received ALUNBRIG experienced new or worsening hyperglycemia. Grade 3 hyperglycemia, based on laboratory assessment of serum fasting glucose levels, occurred in 3.7% of patients. Two of 20 (10%) patients with diabetes or glucose intolerance at baseline required initiation of insulin while receiving ALUNBRIG. Assess fasting serum glucose prior to initiation of ALUNBRIG and monitor periodically thereafter. Initiate or optimize anti-hyperglycemic medications as needed. If adequate hyperglycemic control cannot be achieved with optimal medical management, withhold ALUNBRIG until adequate hyperglycemic control is achieved and consider reducing the dose of ALUNBRIG or permanently discontinuing ALUNBRIG.

Embryo-Fetal Toxicity: Based on its mechanism of action and findings in animals, ALUNBRIG can cause fetal harm when administered to pregnant women. There are no clinical data on the use of ALUNBRIG in pregnant women. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective non-hormonal contraception during treatment with ALUNBRIG and for at least 4 months following the final dose. Advise males with female partners of reproductive potential to use effective contraception during treatment and for at least 3 months after the last dose of ALUNBRIG.

ADVERSE REACTIONS

Serious adverse reactions occurred in 38% of patients in the 90 mg group and 40% of patients in the 90→180 mg group. The most common serious adverse reactions were pneumonia (5.5% overall, 3.7% in the 90 mg group, and 7.3% in the 90→180 mg group) and ILD/pneumonitis (4.6% overall, 1.8% in the 90 mg group and 7.3% in the 90→180 mg group). Fatal adverse reactions occurred in 3.7% of patients and consisted of pneumonia (2 patients), sudden death, dyspnea, respiratory failure, pulmonary embolism, bacterial meningitis and urosepsis (1 patient each).

The most common adverse reactions (≥25%) in the 90 mg group were nausea (33%), fatigue (29%), headache (28%), and dyspnea (27%) and in the 90→180 mg group were nausea (40%), diarrhea (38%), fatigue (36%), cough (34%), and headache (27%).

DRUG INTERACTIONS

CYP3A Inhibitors: Avoid concomitant use of ALUNBRIG with strong CYP3A inhibitors. Avoid grapefruit or grapefruit juice as it may also increase plasma concentrations of brigatinib. If concomitant use of a strong CYP3A inhibitor is unavoidable, reduce the dose of ALUNBRIG.

CYP3A Inducers: Avoid concomitant use of ALUNBRIG with strong CYP3A inducers.

CYP3A Substrates: Coadministration of ALUNBRIG with CYP3A substrates, including hormonal contraceptives, can result in decreased concentrations and loss of efficacy of CYP3A substrates.

USE IN SPECIFIC POPULATIONS

Pregnancy: ALUNBRIG can cause fetal harm. Advise females of reproductive potential of the potential risk to a fetus.

Lactation: There are no data regarding the secretion of brigatinib in human milk or its effects on the breastfed infant or milk production. Because of the potential adverse reactions in breastfed infants, advise lactating women not to breastfeed during treatment with ALUNBRIG.

Females and Males of Reproductive Potential:

Contraception: Advise females of reproductive potential to use effective non-hormonal contraception during treatment with ALUNBRIG and for at least 4 months after the final dose. Advise males with female partners of reproductive potential to use effective contraception during treatment with ALUNBRIG and for at least 3 months after the final dose.

Infertility: ALUNBRIG may cause reduced fertility in males.

Pediatric Use: The safety and efficacy of ALUNBRIG in pediatric patients have not been established.

Geriatric Use: Clinical studies of ALUNBRIG did not include sufficient numbers of patients aged 65 years and older to determine whether they respond differently from younger patients. Of the 222 patients in ALTA, 19.4% were 65-74 years and 4.1% were 75 years or older. No clinically relevant differences in safety or efficacy were observed between patients ≥65 and younger patients.

Hepatic or Renal Impairment: No dose adjustment is recommended for patients with mild hepatic impairment or mild or moderate renal impairment. The safety of ALUNBRIG in patients with moderate or severe hepatic impairment or severe renal impairment has not been studied.

Please see the full U.S. Prescribing Information for ALUNBRIG at www.ALUNBRIG.com

About Takeda Pharmaceutical Company

Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and neuroscience therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. Innovative products, especially in oncology and gastroenterology, as well as Takeda’s presence in emerging markets, are currently fueling the growth of Takeda. Approximately 30,000 Takeda employees are committed to improving quality of life for patients, working with Takeda’s partners in health care in more than 70 countries. For more information, visit https://www.takeda.com/newsroom/.

Additional information about Takeda is available through its corporate website, www.takeda.com, and additional information about Takeda Oncology, the brand for the global oncology business unit of Takeda Pharmaceutical Company Limited, is available through its website, www.takedaoncology.com.


Contacts

Takeda Pharmaceutical Company Limited
Japanese Media
Kazumi Kobayashi, +81 3 3 278 2095
kazumi.kobayashi@takeda.com
or
European Media
Kate Burd, +41 79 514 9533
kate.burd@takeda.com
or
Media outside Japan/EU
Shant Salakian, +1-617-444-3334
Shant.Salakian@takeda.com


Permalink : http://aetoswire.com/news/takeda-announces-phase-3-trial-of-alunbrigreg-brigatinib-met-primary-endpoint-demonstrating-superiority-in-progression-free-survival-versus-crizotinib-in-patients-with-alk-advanced-nsclc-who-are-alk-inhibitor-naiumlve/en

Fitch Solutions Launches Macro Intelligence Solutions as Part of Strategic Growth Plan



SINGAPORE & NEW YORK & LONDON-Monday 30 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- As part of its strategic growth plan, Fitch Solutions today announced the launch of its Macro Intelligence Solutions which integrates BMI Research into the Fitch Solutions content suite and combines Fitch Ratings credit insights with BMI expertise, providing clients with one authoritative voice for credit and macro intelligence.

“The full integration of BMI Research is a key milestone for Fitch Solutions. The addition of BMI’s 150 expert analysts to the Fitch Solutions offering is a further step forward in our strategy to expand our content portfolio, invest in our macro intelligence platform and provide clients with a comprehensive and consolidated suite of solutions that leverage technology, research, data and analytics,” said Dr. Ranjit Tinaikar, President, Fitch Solutions.

“Closely following the acquisition of Fulcrum Financial Data, this is an important step forward in the growth plans and trajectory of Fitch Solutions and we look forward to continuing expansion and momentum in our business,” Dr. Tinaikar added.

“The creation of our Macro Intelligence Solutions offering, incorporating BMI’s proprietary macro data and unparalleled breadth of coverage and sector research covering more than 200 markets and 22 industries, is an important development in the ongoing expansion of our solutions capabilities and allows us to provide our clients with a truly integrated offering via our Fitch Connect platform,” said Brian Filanowski, Global Head of Product and Solutions, Fitch Solutions.

As an industry leading data provider, the Fitch Solutions business is built on three solutions-based offerings: Macro Intelligence Solutions, Counterparty Risk Solutions and Debt Market Solutions.

BMI research coverage remains unchanged. Going forward, all BMI Research content - across research, data and reports - will be fully integrated into Fitch Solutions Macro Intelligence Solutions and available to all subscribers on Fitch Connect (www.fitchconnect.com). The BMI brand will be replaced by Fitch Solutions Macro Intelligence Solutions.

Fitch Solutions is an industry-leading provider of credit, debt market, and macro intelligence solutions, and the primary distributor of Fitch Ratings content. Today, 90% of the world’s leading banks and financial institutions, as well as multinational companies, government agencies, and consulting firms based across the globe depend on Fitch content to inform their business decisions.

Fitch Solutions is part of Fitch Group, a global leader in financial information services with operations in more than 30 countries. Fitch Group is wholly-owned by Hearst.

Contacts

For Fitch Solutions:
Media Relations:
Peter Hoflich, +65 6576 5823
Peter.Hoflich@fitchsolutions.com;
or
London:
Athos Larkou, +44 20 3530 1549
athos.larkou@fitchratings.com


Permalink : http://aetoswire.com/news/fitch-solutions-launches-macro-intelligence-solutions-as-part-of-strategic-growth-plan/en

WeWork Announces $500 Million Series B Investment in WeWork China Led by Trustbridge, Temasek, SoftBank and Hony Capital



NEW YORK & TOKYO & SHANGHAI-Saturday 28 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- WeWork Companies (“WeWork”) today announced a $500 million Series B investment in WeWork China led by Trustbridge Partners (“Trustbridge”), Temasek, the SoftBank Group (“SoftBank”), the SoftBank Vision Fund (“Vision Fund”) and Hony Capital. This funding will accelerate WeWork’s growth in China, allowing the company to serve more entrepreneurs, creators, and enterprises across the region through the unparalleled design, technology, hospitality and local community WeWork provides.

In the two years since opening its first location in China, WeWork has become a trusted local partner to creators and businesses of all sizes, providing 20,000 members across nearly 40 locations in three cities with the community, culture, and services to start and scale their operations. WeWork has also enabled more global businesses to have a presence in China, and helped Chinese businesses to both scale within the country and expand around the world. In July 2017, WeWork announced the creation of WeWork China, with a $500 million Series A investment from Hony Capital and SoftBank dedicated entirely to accelerating WeWork’s expansion across China.

“We are grateful to our partners at Trustbridge, Temasek, SoftBank, and Hony for their belief in our vision and their support of our business. This investment will help WeWork fuel our mission to support creators, small businesses and large companies across China. WeWork has built an incredible team in China that supports our members every day, serving as a bridge for local companies who want to reach the world as well as for global companies that want to enter the Chinese market. While there is still much to do and learn, this investment highlights the potential for WeWork and our community of creators in the region and reaffirms our dedication to our team, our members and our partners in China,” said WeWork Co-Founder and CEO Adam Neumann.

“Trustbridge is pleased to join the WeWork China team. Through its thoughtful design, technology, hospitality and most importantly community, WeWork is paving the way for a new future of work in China and supporting the transformation from Made in China to Created in China. Whether entrepreneurs are just starting out, Chinese companies are looking to take their business global, or international enterprises want to do business here, they know WeWork is the local partner they need,” said Feng Ge, Managing Partner of Trustbridge Partners.

“Adam Neumann’s vision has always been for WeWork to be a global company with a local playbook, and nowhere is that more clear than in China where WeWork has developed an impressive offering. From its strong leadership team to locally-tailored technology integrations and community-based design, WeWork has demonstrated that it understands what businesses in China need to succeed. Through this investment, we look forward to WeWork continuing to support many more companies of all sizes across China,” said Ronald D. Fisher, Director, Vice Chairman of SoftBank Group Corp.

“Over the past two years, we’ve seen what WeWork’s growing presence in China can accomplish. WeWork is a global connector bringing entrepreneurs, startups and large enterprise companies from around the world together, a local partner supporting Chinese entrepreneurs and attracting new businesses to invest in China, and an innovator reimagining the workspace through its cutting-edge design, technology and community-focused culture. With our continued investment, we know WeWork will continue to lead in the future of work,” said John Zhao, Chairman and Chief Executive Officer of Hony Capital.

About WeWork

WeWork provides its members around the world with space, community, and services through both physical and virtual offerings. From startups and freelancers to small businesses and Fortune 500 companies, our community is united by a desire for our members to create meaningful work and lead meaningful lives—to be a part of something greater than ourselves. Co-founded by Adam Neumann and Miguel McKelvey in New York City in 2010, WeWork is a privately held company with over 5000 employees. Follow us @WeWork on Twitter, Instagram, and Facebook or visit wework.com to learn more.

About Trustbridge

Trustbridge Partners is a leading growth equity fund that focuses on investing in high-quality growth opportunities in China. Founded in 2006, Trustbridge currently manages approximately $8 billion in assets from leading university endowments, pension funds, sovereign wealth funds, and strategic industry partners. Our investment philosophy is built upon a fundamental understanding of long-term trends in demographics, technology and structural changes. We adopt a unique ecosystem-driven approach and concentrate in the Internet, content / education, and healthcare sectors where we believe our deep insights and strong industry relationships help generate unique investing opportunity sets.

About Temasek

Incorporated in 1974, Temasek is an investment company headquartered in Singapore. Supported by 11 offices internationally, Temasek owns a US$235b portfolio as at 31 March 2018. Our portfolio covers a broad spectrum of industries: financial services; telecommunications, media & technology; transportation & industrials; consumer & real estate; life sciences & agribusiness; as well as energy & resources. Investment activities are guided by four investment themes and the long term trends they represent: Transforming Economies; Growing Middle Income Populations; Deepening Comparative Advantages; and Emerging Champions. For more information on Temasek, please visit www.temasek.com.sg

About Hony Capital

Hony Capital, founded in 2003 and sponsored by Legend Holdings, specializes in buyout investment. Partnering with the world’s leading investors, it focuses on the development of China’s real economy with “Value creation, Price Realization” as its investment philosophy. Hony Capital currently has USD 10 billion under management, with investors from China and the world’s leading investment institutions, including national pension funds, sovereign wealth funds, university endowment funds, regional and industry pensions, insurance companies, family foundations, individual investors and other types. Hony Capital puts China as its top market, with investments in over 100 companies in areas of pharmaceutical and healthcare, media and entertainment, consumer products, food and beverage, as well as machinery and equipment manufacturing. Hony Capital’s portfolio companies include China Shijiazhuang Pharmaceutical Group (CSPC), Zoomlion, China International Marine Containers (CIMC), Suning, Chengtou Holding, Jin Jiang International Hotels, ENN, PizzaExpress (UK), STX(US) , WeWork (US) , ofo, COFCO Capital, etc. The assets value of these companies totals about RMB 2.9 trillion with sales volume of RMB 860 billion, providing more than 450,000 jobs.



Contacts

WeWork
Dominic McMullan / Gwen Rocco / Jenny Chan
press@wework.com
or
Trustbridge
Public Relations
pr@trustbridgepartners.com
or
Hony Capital
Victoria Li
victoriali@honycapital.com

Permalink : http://aetoswire.com/news/wework-announces-500-million-series-b-investment-in-wework-china-led-by-trustbridge-temasek-softbank-and-hony-capital/en

Sunday, July 29, 2018

HRH The Crown Prince of the Kingdom of Saudi Arabia Mohammed Bin Salman Names Renowned Tourism Impresario Gerard “Jerry” Inzerillo to Lead Transformative Heritage Tourism Initiative

Inzerillo to Be First-Ever CEO of the Diriyah Gate Development Authority, Encompassing Museums, Universities, Major "Edutainment" Facilities as well as Resorts, Restaurants, Wellness Centers and Luxury Retail


RIYADH, Saudi Arabia-Wednesday 25 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- His Royal Highness Mohammed Bin Salman Bin Abdulaziz Al Saud, Crown Prince of the Kingdom of Saudi Arabia and Chairman of the Diriyah Gate Development Authority (DGDA) has named Gerard “Jerry” Inzerillo CEO of the Authority, which will spearhead a transformative initiative to restore the historic birthplace of the Saudi state.

Inzerillo, a highly accomplished tourism visionary, was selected to oversee the restoration of Diriyah and to develop a number of major new historical and tourism assets including museums, academic institutions and “edutainment” facilities, as well as resorts, restaurants, wellness facilities and high-end retail in a 7.1 million square meter development on the west side of Riyadh, Saudi Arabia’s booming capital city. The initiative is a key deliverable in the Crown Prince’s 2030 Vision to modernize the Saudi state, engage Saudi citizens, and welcome guests from all over the world.

“I am deeply honored to have the privilege to contribute to His Royal Highness’ Dynamic vision for the nation,” said Inzerillo. “This is truly an inspired time in this extraordinary country. I am particularly grateful to lead a world-class team in the development of this historic site, which will give the world its truest window into the soul and spirit of this land, its welcoming people and their rich history. Diriyah will be one of the great gatherings places in the world.”

Diriyah, a UNESCO registered site, holds a historical depth of more than 590 years. As the birthplace of the first, second, and current Kingdom of Saudi Arabia, it is the root of the Saudi nation.

Much of the original site, built in adobe brick in the traditional architecture of the greater Najd region, will be authentically restored with new tourism attractions and facilities.

The At-Turaif District in Diriyah has been designated by UNESCO as a “World Heritage Site.” His Royal Highness envisions Diriyah as a place where the past will be celebrated and the future awakened and where all who enter its gates will be inspired, engaged and entertained.

The DGDA Board of Directors is honored to have attracted such a creative, inspirational leader in Jerry Inzerillo to bring His Royal Highness’ vision into reality. Previously, Inzerillo was CEO of Forbes Travel Guide, the global standard for the verification of service excellence in hospitality. FTG, which operates in more than 100 countries, also awards annually the prestigious Five Star Award, considered the “Olympic Gold Medal of Hospitality”.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180723005793/en/



Contacts

Key Group Worldwide
Jaret Keller
Work: 212-988-7701
Mobile: 917-628-0480
Email: jkeller@keygroup.tv



Permalink : http://aetoswire.com/news/hrh-the-crown-prince-of-the-kingdom-of-saudi-arabia-mohammed-bin-salman-names-renowned-tourism-impresario-gerard-ldquojerryrdquo-inzerillo-to-lead-transformative-heritage-tourism-initiative/en

Multek Announces Completion of Acquisition by Suzhou Dongshan Precision Manufacturing (DSBJ)


HONG KONG-Saturday 28 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Multek, a leading provider of Interconnect Solutions, today announced the completion of its previously announced acquisition by Suzhou Dongshan Precision Manufacturing Co. Ltd. (“DSBJ”) (SZSE: 002384), a diversified manufacturer headquartered in Suzhou, China. The transaction was announced in March 2018 by Multek’s outgoing parent company, Flex (NASDAQ: FLEX), in the form of a divestiture. The completion of this transaction follows the receipt of all necessary shareholder and regulatory approvals.

With the completion of its change in ownership, Multek becomes an indirect, wholly-owned subsidiary of DSBJ. Franck Lize, Chief Executive Officer of Multek, commented, “We are pleased to complete this transaction and very excited about our future as part of the DSBJ family of companies. Multek is now better positioned than ever to continue expanding capabilities and contribute to the combined company’s success, while supporting our customers’ future needs.”

"This transaction represents a new chapter and key milestone in DSBJ's 38-year history," said Yuan Yonggang, Chairman and President of DSBJ. "By acquiring Multek, we are creating a more powerful and global enterprise in the component technology space, with more than 25,000 employees, over five million square feet of manufacturing space, and adding over 300 active customers including the most respected brands in the US, Europe and Asia. With the merger complete, we aim to rapidly grow Multek by repeating the same successful recipe DSBJ used to significantly grow the sales of MFLEX, our last major acquisition in 2016, which was a similar-sized manufacturer in the same industry. In addition, Multek’s large and diversified account base -- spanning Smartphones, Wearables, IoT, Automotive, Medical, Communications Infrastructure, Computing, Consumer Electronics, Industrials and Instrumentation – presents excellent cross-fertilization opportunities for DSBJ’s existing companies and vice-versa."

Founded in 1978, Multek currently operates a 1.6 million square feet campus in Zhuhai, China, offering one-stop engineering and manufacturing services for rigid Printed Circuit Board (PCBs), flexible printed circuits (FPC), rigid-flex, and assembly. Multek’s plants and laboratories are equipped with state-of-the-art equipment.

About Multek

Multek, a wholly owned subsidiary of DSBJ (SZSE: 002384), is a leading value-add manufacturer of printed circuit board technologies offering a broad spectrum of PCB engineering and manufacturing expertise including high density interconnect, rigid, flexible, and rigid-flex printed circuit and assembly solutions. Serving customers in mobile, automotive, IoT, medical, wearable, telecommunications, computing, industrial and consumer electronics markets, Multek enables customers to take products to market quickly through early engineering, advanced technology new product introduction, and volume production. For more information, visit www.multek.com

About DSBJ

DSBJ, founded in 1980 in Suzhou, was successfully listed on the Shenzhen Stock Exchange (stock code: 002384) in 2010. DSBJ aims to be a leading technology provider of critical components in the intelligent world of IoT with one-stop R&D, manufacturing, sales and service for FPC, PCB, Rigid-Flex, LED packaging, Display Modules, and Telecom equipment, which are widely applied in the consumer electronics, telecommunications, and automotive industries. DSBJ achieved annual revenue of USD 2.37 billion in 2017.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180727005287/en/

Contacts

Multek
Peter Yu, +852 2276-1633
peter.yu@multek.com



Permalink : http://aetoswire.com/news/multek-announces-completion-of-acquisition-by-suzhou-dongshan-precision-manufacturing-dsbj/en

Montenegro to Launch New Citizenship-by-Investment Program in October

LONDON-Saturday 28 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Henley & Partners, the leading global investment migration firm, has welcomed the announcement by the Government of Montenegro that it will launch its long-awaited citizenship-by-investment program in October. It follows the decision a few weeks ago by another European nation, Moldova, to award Henley & Partners the mandate to design, implement, and promote its much-anticipated Moldova Citizenship-by-Investment (MCBI) program.

Henley & Partners has accumulated over 20 years of experience working with governments in North America, the Caribbean, Europe, and Asia on the design, set-up, operation, and promotion of some of the world’s most successful residence and citizenship programs, raising more than USD 7 billion in foreign direct investment (FDI).

The firm has been advising the Montenegro Government for more than eight years on the possible introduction of an investment migration program. Dr. Juerg Steffen, Chief Operating Officer at Henley & Partners, says they are looking forward to working with the government to make it a success story for the country. “With Moldova and Montenegro, these two new attractive European programs will significantly diversify and expand the global citizenship-by-investment market. These programs have the potential to create a series of genuinely significant liquidity injections into an economy, both in and of themselves, and as pathfinders for more strategic investments that can help modernize and diversify the economy of often smaller nations, creating a better life for their citizens,” explains Dr. Steffen.

The Montenegro Citizenship-by-Investment Program will be limited to just 2000 applicants during a period of three years with a minimum investment of EUR 250,000. The government will, in addition, charge a fee of EUR 100,000 per application which will be directed to a special fund for underdeveloped areas. Montenegro is ranked 42nd on the Henley Passport Index, offering citizens access to 123 destinations, including Hong Kong, Singapore, the UAE, and all the countries in Europe’s Schengen Area.

“The investment migration industry is maturing. There is both a growing demand from investors for European options, just as developing European sovereign states understand the potentially transformative value of effectively managed citizenship-by-investment programs. It is a mutually beneficial exchange, and it is also very much the direction in which the world is heading, as globalization becomes an undeniable feature of modern life,” concludes Dr. Steffen.

Contacts

Henley & Partners
Sarah Nicklin, +27 21 850 0524
Senior Group PR Manager
sarah.nicklin@henleyglobal.com

Permalink : http://aetoswire.com/news/montenegro-to-launch-new-citizenship-by-investment-program-in-october/en

IBC Best Conference Paper Award Recognises Advances in Artificial Intelligence

BBC R&D paper discusses rules-based AI and machine learning for automated production

LONDON-Saturday 28 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- In a year when artificial intelligence and machine learning became a very hot topic in the media industry, the IBC Best Conference Paper Award goes to a team from BBC R&D which has investigated practical applications. The award is made to the technical paper which, according to the team of peer reviewers, delivers not just the most significant new research, but does so in an accessible way.

The paper, ‘AI in production: video analysis and machine learning for expanded live events coverage’, will be presented at midday on Sunday 16 September as part of a new initiative at IBC2018 – ‘Tech Talks’. ‘Tech Talks’ ensures that the highly respected technical papers remain an integral part of IBC and its conference, bringing the latest ideas to all delegates in a fresh and accessible form.

Talking of the new innovation, Dr Nick Lodge, executive producer of technical sessions in the conference, said “Senior technologists and researchers who have been responsible for original and thought-provoking advances in media technology will talk about their own work, and audiences will have the rare opportunity to question these world experts.

“The technologies that impact the media industry are broad,” he added. “This year’s ‘Tech Talks’ will cover emerging areas like artificial intelligence, virtual and augmented reality, 5G and blockchain.”

In the award-winning paper a team of BBC researchers covering a wide range of skills, under project lead Mike Evans, discuss a project known as ‘Ed’. This prototype system is used to create near-live content with minimal crew. An example might be a set of three unmanned 4K cameras, from which ‘Ed’ would produce a number of properly framed HD pictures, cutting between them as appropriate.

“The point of the work is to allow coverage of more events, to reach places we otherwise could not reach,” Mike Evans said. “With conventional production we cover only about six of the nearly 100 places music is performed at the Glastonbury Festival, for example, or just a tiny fraction of the 50,000 performances in 300 venues at the Edinburgh Fringe.”

“But with ‘Ed’ we can reach many more of these and do so with production techniques which are much less intrusive for the event itself,” he explained. “This technology will be suitable not just for major production companies like the BBC, but for a whole range of use cases, like minor sports which need to increase visibility, and even vloggers who want to improve their online presence.”

Dr Paul Entwistle, Chair of the IBC Technical Papers Committee which provides careful peer review of the many papers proposed for IBC, said “The detail in this paper is absolutely fascinating. The team has developed an artificial intelligence system that understands the rhythms and cadences that make for professional video production. This was validated by research to see how well ‘Ed’ performs compared with a real director, and how the audience perceived the viewing experience.”

The authors winning this year’s IBC Best Conference Paper are Craig Wright (who will be presenting it at IBC), Jack Allnut, Rosie Campbell, Michael Evans, Ronan Forman, James Gibson, Stephen Jolly, Lianne Kerlin, Zuzanna Lechelt, Graeme Phillipson and Matthew Shotton, all from BBC R&D. They will be presented with the award as part of the IBC Awards Ceremony, on Sunday evening 16 September at 18:30 in the Auditorium.

The ceremony will see the presentation of all of IBC’s awards, including the International Honour for Excellence. Attendance is free for all IBC visitors.

Notes to Editors:

For more information about IBC2018 visit: show.ibc.org

About IBC
IBC is the world’s most influential media, entertainment and technology show. It attracts 57,000+ attendees from more than 170 countries and combines a highly respected and peer-reviewed conference with an exhibition that showcases more than 1,700 leading suppliers of state-of-the-art electronic media and entertainment technology.

IBC2018 Dates
Conference: 13 - 17 September 2018

Exhibition: 14 - 18 September 2018

For more information about IBC2018 visit: show.ibc.org/



Contacts
IBC
Louise Wells, Bubble Agency
E: louisew@bubbleagency.com
T: +44 7718 985 252


Permalink : http://aetoswire.com/news/ibc-best-conference-paper-award-recognises-advances-in-artificial-intelligence/en

Saturday, July 28, 2018

Standard & Poor’s Reaffirms IGI’s A- Rating with Stable Outlook

HAMILTON, Bermuda-Tuesday 24 July 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Rating agency S&P Global has reaffirmed the financial strength rating of A- with a stable outlook for International General Insurance (IGI), the global specialist commercial insurer and reinsurer.

IGI’s issuer credit and insurer financial strength ratings were reaffirmed by S&P, despite a catastrophe-heavy year in 2017, resulting in additional liability charges.

“S&P reaffirming our A- rating reflects the consistency of our underwriting strategy, strength of our balance sheet and high-calibre talent.” said Wasef Jabsheh, Chief Executive Officer of IGI. “Even in a cat-heavy 2017, IGI’s sound underwriting performance helped us to maintain continued profitability and capital adequacy.”

In its report, S&P said: “IGI’s sound underwriting performance continues as seen in its five-year average net combined ratio of 88% and average net profits of $30 million.”

S&P praised IGI’s business risk profile, calling IGI a “relatively small but geographically-diversified facultative insurer, with a good operating performance”. The rating agency also commented on IGI’s strong capitalisation and effective control over its insurance and catastrophe risks.

“This affirmation will help IGI continue to improve the performance of its core operations and strengthen its balance sheet,” Hatem Jabsheh, Chief Operations Officer at IGI, added. “S&P recognised the investment IGI made in improving its risk capital and analytics software in 2017, which set out to facilitate a more predictable underwriting performance, while creating operational effectiveness.

“This rating is a confirmation of our programme of prudent, well-managed growth matched with increased adoption of technology and innovation,” Mr Jabsheh commented.

In April, IGI published a paper outlining how it modernised its risk, capital and actuarial modelling capabilities to improve the way the company evaluates its own risk. To read the full report, see https://www.iginsure.com/financial/white-papers/.

S&P said: “In our opinion, IGI benefits from an experienced management team. It has also proven

successful in attracting high-calibre technical and underwriting staff from around the world, and has been able to consistently define and achieve its strategic objectives.”

Issued by rein4ce on behalf of International General Insurance Holding Limited.

About IGI:

International General Insurance Holdings Limited is registered in the Dubai International Financial Centre (DIFC) with operations in Bermuda, Jordan, UAE, Malaysia, Morocco and a wholly owned subsidiary in the UK.

IGI Bermuda is a class 3B (re)insurer regulated by the Bermuda Monetary Authority (BMA). This subsidiary is the principal underwriting entity for the Group. The Group also has a branch in Labuan, Malaysia, registered as a second-tier offshore reinsurer.

Both IGI Bermuda and IGI UK are rated A- with a stable outlook by Standard & Poor’s and A- (Excellent) with a positive outlook by A.M Best Company.

IGI Group of companies underwrites a worldwide portfolio of energy, property, marine, engineering, casualty, legal expenses, directors and officers, financial institutions, general aviation, ports & terminals, political violence, forestry and reinsurance treaty.

International General Insurance Holdings Limited had assets in excess of US$ 888 million as at 31st December 2017.

For more information, please visit www.iginsure.com or email info@iginsure.com.

Contacts

rein4ce
Sarah Hills
T: +44 (0)7718 882011
Email: sarah.hills@rein4ce.co.uk
or
IGI
Aaida Abu Jaber
PR & Marketing Manager
T: +96265662082 Ext. 311
M: +962770415540
Email: Aaida.AbuJaber@iginsure.com

Permalink : http://aetoswire.com/news/standard-amp-poorrsquos-reaffirms-igirsquos-a-rating-with-stable-outlook/en